Also, these accumulated genetic mutations regulate oncogenic signaling pathways and the activation of transcription factors such as HIF1A, conferring a survival advantage by facilitating rapid cell proliferation and adaptation to the hypoxic tumor microenvironment (49). The gene discussed is HIF1A; the disease is neoplasm.